First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial
一线治疗方案为英夫利昔单抗与常规治疗方案在初诊中重度克罗恩病患儿中的疗效比较:一项开放标签、多中心、随机对照试验
期刊:Gut
影响因子:25.8
doi:10.1136/gutjnl-2020-322339
Jongsma, Maria M E; Aardoom, Martine A; Cozijnsen, Martinus A; van Pieterson, Merel; de Meij, Tim; Groeneweg, Michael; Norbruis, Obbe F; Wolters, Victorien M; van Wering, Herbert M; Hojsak, Iva; Kolho, Kaija-Leena; Hummel, Thalia; Stapelbroek, Janneke; van der Feen, Cathelijne; van Rheenen, Patrick F; van Wijk, Michiel P; Teklenburg-Roord, Sarah T A; Schreurs, Marco W J; Rizopoulos, Dimitris; Doukas, Michail; Escher, Johanna C; Samsom, Janneke N; de Ridder, Lissy